CORC  > 上海药物研究所  > 中国科学院上海药物研究所
A positive feedback regulation of Heme oxygenase 1 by CELF1 in cardiac myoblast cells
Liu, Yang5,6; Wang, Huiwen4,6; Wang, Jun5,6; Wei, Bin3; Zhang, Xinyi5,6; Zhang, Mengqi5,6; Cao, Dong2; Dai, Jiang1; Wang, Zhen4; Nyirimigabo, Eric5,6
刊名Biochimica et biophysica acta. Gene regulatory mechanisms
2018-11-30
ISSN号1876-4320
DOI10.1016/j.bbagrm.2018.11.006
文献子类Article
英文摘要As an RNA binding protein, CUG-BP Elav-like family (CELF) has been shown to be critical for heart biological functions. However, no reports have revealed the function of CELF1 in hypertrophic cardiomyopathy (HCM). Hinted by RNA immunoprecipitation-sequencing (RIP-seq) data, the influence of the CELF protein on heme oxygenase-1 (HO-1) expression was tested by modulating CELF1 levels. Cardiac hypertrophy is related to oxidative stress-induced damage. Hence, the cardiovascular system may be protected against further injury by upregulating the expression of antioxidant enzymes, such as HO-1. During the past two decades, research has demonstrated the central role of HO-1 in the protection against diseases. Thus, understanding the molecular mechanisms underlying the modulation of HO-1 expression is profoundly important for developing new strategies to prevent cardiac hypertrophy. To elucidate the molecular mechanisms underlying HO-1 regulation by the CELF protein, we performed RNA immunoprecipitation (RIP), biotin pull-down analysis, luciferase reporter and mRNA stability assays. We found that the expression of HO-1 was downregulated by CELF1 through the conserved GU-rich elements (GREs) in HO-1 3'UTR transcripts. Correspondingly, CELF1 expression was regulated by controlling the release of carbon monoxide (CO) in H9C2 cells. The CELF1-HO-1-CO regulation axis constituted a novel positive feedback circuit. In addition, we detected the potential involvement of CELF1 and HO-1 in samples from HCM patients. We found that CELF1 and CELF2, but not HO-1, were highly expressed in HCM heart samples. Thus, a manipulation targeting CELF1 could be developed as a potential therapeutic option for cardiac hypertrophy.
语种英语
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/266345]  
专题中国科学院上海药物研究所
通讯作者Wang, Huiwen; Ji, Guangju
作者单位1.Department of Cardiovascular Surgery Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100000, China
2.Laboratory Animal Center, Peking University, Beijing 100871, China;
3.Michigan Surgical Hospital, 21230 Dequindre Road, Warren, MI 48091, USA;
4.State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China;
5.University of the Chinese Academy of Sciences, Beijing 100049, China;
6.National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China;
推荐引用方式
GB/T 7714
Liu, Yang,Wang, Huiwen,Wang, Jun,et al. A positive feedback regulation of Heme oxygenase 1 by CELF1 in cardiac myoblast cells[J]. Biochimica et biophysica acta. Gene regulatory mechanisms,2018.
APA Liu, Yang.,Wang, Huiwen.,Wang, Jun.,Wei, Bin.,Zhang, Xinyi.,...&Ji, Guangju.(2018).A positive feedback regulation of Heme oxygenase 1 by CELF1 in cardiac myoblast cells.Biochimica et biophysica acta. Gene regulatory mechanisms.
MLA Liu, Yang,et al."A positive feedback regulation of Heme oxygenase 1 by CELF1 in cardiac myoblast cells".Biochimica et biophysica acta. Gene regulatory mechanisms (2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace